SCHEMBL6565538

SCHEMBL6565538

O=C(Nc1cc(F)c(O)c(F)c1)Nc1ccccc1C(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
KDM4E B2RXH2 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 2/20 0.59
THRB P10828 1/20 0.59
NOX1 Q9Y5S8 1/20 0.59
TRPV1 Q8NER1 3/20 0.55
TSHR P16473 1/20 0.54
GRIK1 P39086 1/20 0.52
POLB P06746 3/20 0.50
MAPK1 P28482 1/20 0.50
TP53 P04637 1/20 0.48
CXCR2 P25025 2/20 0.48
LMNA P02545 1/20 0.48
KDR P35968 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4349649 0.83 KMT2A (0.61) KDM4EKMT2AALDH1A1SMN1; SMN2
SCHEMBL22567818 0.82 KDR (0.60) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL7759976 0.82 MEN1 (0.68) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL6565658 0.80 TRPV1 (0.66) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL4354644 0.79 DDX3X (0.65) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6567619 0.79 KMT2A (0.65) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL4350139 0.78 SMN1; SMN2 (0.63) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24732382 0.77 KDR (0.73) RAB9AKDM4EMEN1KMT2AALDH1A1
SCHEMBL4341621 0.77 KDM4E (0.66) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL4349655 0.77 ALDH1A1 (0.43) NPC1RAB9AKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed